Biotech Firm Dissolves, Terminates 85K SF Cambridge Lease With Alexandria

Rubius Therapeutics, a life sciences company that went public at a $2B valuation in 2018, has now dissolved and liquidated assets including its headquarters in Cambridge and it’s Manufacturing facility in Rhode Island
Read more